How to Comply with Indonesia’s Cosmetic PIF Requirements

Entering Indonesia's booming beauty market hinges on a single, highly scrutinized dossier: the Product Information File (PIF). Without a rock-solid hat strictly aligns with BPOM’s technical ingredient restrictions, your market entry can stall before it even begins.

The PIF serves as the central compliance dossier for a cosmetic product and demonstrates that the formulation, ingredients, claims, and safety profile meet the standards established by the Indonesian Food and Drug Authority (BPOM). 

Because BPOM aggressively audits these files, getting it wrong is costly. Failing to meet compliance guidelines can trigger severe penalties, ranging from administrative warnings to forced product recalls and the total revocation of your cosmetic notification numbers.

Continue reading for a complete guide to Indonesia's cosmetic PIF requirements. For support with cosmetic registration in Indonesia, explore our notification services or request a proposal today.

What Is a Product Information File (PIF)?

Governed by BPOM Regulation No. 17 of 2023, a PIF is a mandatory, lifecycle regulatory dossier that must be fully compiled before you can submit the notification application and launch your product. Rather than functioning as a static list of ingredients, the PIF serves as an active legal and scientific testament. It acts as the primary vehicle to prove your product complies with BPOM's technical ingredient regulations by translating your lab data into verified regulatory evidence.

To clear BPOM's high bar, every file must present an unbroken chain of logic proving that your raw ingredients are safe, correctly restricted by concentration, and perform functions that align perfectly with your retail packaging claims. Without this foundational proof, demonstrating compliance during sudden regulatory reviews or post-market field inspections becomes nearly impossible.

“Think of your Product Information File as your passport to Indonesia’s booming beauty market.”– Elysabeth Septiani

The Compliance Standard: BPOM Regulation No. 25 of 2025

When BPOM audits a PIF, they evaluate it against the technical requirements established under BPOM Regulation No. 25 of 2025. This regulation demands that every cosmetic ingredients and formulation adheres strictly to three core pillars:

• Safety: The formulation poses no health risks under normal conditions of use
• Quality: The product meets consistent, standardized manufacturing and purity metrics
• Benefit: The cosmetic achieves the specific consumer improvements advertised on the label

Manufacturers must be able to demonstrate compliance with these principles using appropriate supporting evidence, which may include:

• Laboratory testing
• Scientific studies
• Toxicological assessments
• Empirical safety data
• Product performance evidence

Which Cosmetic Ingredients Are Permitted in Indonesia?

To pass a BPOM review, your formulation must map precisely against the active regulatory registers established by Indonesian law. BPOM classifies cosmetic ingredients into several distinct categories:

• Ingredients Allowed with Restrictions: Substances permitted only under rigid boundaries, including maximum concentration caps, specific product category limits (e.g., facial-only restrictions), or mandatory packaging warnings. 
• Regulated Functional Ingredients: Functional groups like colorants, preservatives, and UV filters are highly gatekept. Only chemicals explicitly named on BPOM's active positive lists may be used for these specific purposes. 
• Prohibited Ingredients: Substances on BPOM’s negative list are strictly prohibited. These cannot be salvaged or justified by independent testing. 
• Non-Listed & Natural Ingredients: Ingredients missing from the standard annexes face steep regulatory hurdles. However, Indonesia offers unique flexibility for indigenous natural ingredients, provided their safety and efficacy are backed by flawless scientific or empirical data. 
• Nanomaterials: Formulations featuring nanotechnology face heightened technical characterization audits. Furthermore, any nano-form ingredient must be clearly declared on product packaging with a specific "(nano)" suffix. 
• Impurities and Contaminants: Trace amounts of prohibited impurities (such as mercury) are tolerated only if they are technically unavoidable under Good Manufacturing Practices and fall safely below BPOM's strict parts-per-million (ppm) thresholds.

What Should a Cosmetic Product Information File Include?

BPOM requires cosmetic PIFs to be organized into four main sections. Together, these parts must assemble an airtight technical story from legal registration to clinical data.

Part I: Administrative Documentation

The first section contains administrative information related to the manufacturer, importer, and product authorization.

Typical documents include:

• Business licenses
• Good Manufacturing Practice (CPKB) certificates
• Authorization letters for imported products
• Contract manufacturing agreements
• Supporting legal documentation

These documents establish the legal basis for product manufacturing and distribution.

Part II: Raw Material Quality and Safety

The second section focuses on ingredient compliance and safety.

Manufacturers should include:

• Raw material specifications
• Ingredient identity information
• Supplier documentation
• Safety data
• Quality information

Manufacturers must be able to show that ingredients comply with:

• Permitted ingredient lists
• Applicable restrictions
• Safety requirements
• Scientific justification requirements

Part III: Finished Product Quality

Here, you provide the technical records demonstrating that your final formulation is consistently stable and uniform over its commercial life.

Information typically includes:

• Full formulation
• INCI ingredient listing
• Percentage composition
• Manufacturing process description
• Product specifications
• Stability study data

Part IV: Safety and Benefit Evidence

The final section contains the scientific evidence supporting product safety and cosmetic claims.

Typical documentation includes:

• Safety assessments
• Toxicological evaluations
• Adverse event information
• Product claim substantiation
• Labeling compliance documentation

Manufacturers should ensure that all cosmetic claims are supported by appropriate evidence and that product labeling accurately reflects the supporting documentation contained within the PIF.

Maintaining Compliance After Entering Indonesia’s Cosmetics Market

Compliance does not end once a product has been notified. Manufacturers remain responsible for maintaining an accurate Product Information File and ensuring ongoing compliance throughout the product's lifecycle.

To prevent costly penalties during unannounced post-market inspections, brands must establish active operational procedures to:

• Dynamically update PIF records as raw material suppliers or packaging designs evolve
• Continuously monitor ingredient restrictions against shifting BPOM updates
• Run proactive surveillance to track post-market safety and consumer adverse events
• Regularly audit marketing claims to ensure ongoing alignment with technical data

Navigating this long-term maintenance requires continuous vigilance. Aligning with an experienced local regulatory partner can streamline these obligations, protect your notification status, and significantly mitigate compliance risks.

Common Compliance Risks That Delay Cosmetic Notifications

Manufacturers can reduce the risk of delays during notification and post-market compliance issues by reviewing formulations, supporting documentation and product claims before submission. The following are some of the most common compliance risks, along with practical ways to address them.

Addressing these issues during product development is generally more efficient than correcting them after regulatory review.

Without supporting evidence in the PIF, demonstrating compliance with Indonesia's technical requirements becomes significantly more difficult during regulatory review or post-market inspections.

Final Thoughts

Far more than a static binder of documents, the Product Information File is your definitive scientific defense proving that your product's ingredients, manufacturing quality, consumer safety, and marketing claims align perfectly with BPOM mandates.

Yet, translating local regualtory frameworks and keeping a living dossier compliant across a product's entire lifecycle can be daunting for international brands. Cisema helps manufacturers overcome these challenges by providing cosmetic notification support, precise ingredient compliance assessments, local representation, and strategic regulatory guidance throughout Indonesia and the wider Southeast Asian market.

If you're planning to introduce cosmetics into Indonesia, contact Cisema today to assess your products, strengthen your regulatory strategy, and clear your path to market entry.

Further Information

Explore Cisema’s services for cosmetics notification in Indonesia.

About the Author: Elysabeth Septiani

Elysabeth Septiani is a Regulatory Affairs Manager at Cisema, Indonesia, overseeing regulatory strategy and compliance for medical devices, supplements, and cosmetic products. With eight years of experience in Regulatory Affairs and Quality Assurance, she specializes in regulatory submissions and intelligence, supporting efficient and compliant market access while ensuring alignment with evolving regulatory requirements.

References

• BPOM Regulation No. 17 of 2023 – Cosmetic Product Information File Guideline‍
• BPOM Regulation No. 25 of 2025 – Technical Requirements for Cosmetic Ingredients‍
• Why Indonesia’s beauty market is growing faster than ever